not been systematically addressed (1) . Although surveillance has been reported as an effective tool for the reduction of VAP in the developed world (4), the importance of surveillance for measuring AICU patient infection risks, outcomes, and processes in limited-resource countries remains many times under-recognized (1, 5) . As a countervailing strategy, in 2002 the International Nosocomial Infection Control Consortium (INICC) developed an outcome and process surveillance program specifically designed for intensive care units (ICUs) in developing countries (6) (7) (8) .
Through the implementation of the INICC program, it was demonstrated that there was a notable difference in the VAP rates between the ICUs of hospitals from the industrialized world and those from limited-resource healthcare settings, with rates that were three to five times higher in the latter ones (9-18).
In the INICC program, the multidimensional approach for VAP, the infection-prevention bundle was based on the guidelines published by the Society for Health Care Epidemiology of America and the Infectious Diseases Society of America, which describe evidence-based interventions and recommendations for VAP prevention in the ICU (19) . These guidelines provide feasible and costeffective infection-control measures, relatively applicable to developing countries. In addition, the INICC prevention bundle also followed the recommendation by the Institute of Healthcare Improvement that a ventilator bundle be implemented at every ICU to reduce the occurrence rate of VAP to zero, which was part of the 5 Million Lives campaign, endorsed by leading U.S. agencies and professional societies (20) .
Nevertheless, very few studies have been conducted and shown successful interventions for VAP reduction, which would serve as guidance for tackling this problem (1) . Likewise, study heterogeneity in developing countries may cause variation in the reported rates (1) .
Within the context of developing countries, outcome and process surveillance, integrated in an intervention bundle with performance feedback of infection-control practices, has been shown to successfully reduce and control DAIs in different studies conducted in INICC member hospitals (21) (22) (23) (24) (25) .
For analytical purposes, the World Bank classifies economies as low income, middle income, or high income. As of 1 July 2011 low-income economies are those that had average incomes of $1,005 or less in 2010; lower-middle-income economies had average incomes of $1,006 to $3,975; upper-middle-income economies had average incomes of $3,976 to $12,275; and high-income had average incomes of $12,276 or more. Low-and middle-income economies are commonly referred to as developing economies. However, this does not imply that economies in the same income group have reached similar stages of development or that high-income economies have reached a preferred or final stage of development. In this study we included two lower-middleincome economies (India and Morocco), and 12 upper-middle-income economies (Argentina, Brazil, China, Colombia, Costa Rica, Cuba, Lebanon, Macedonia, Mexico, Panama, Peru, and Turkey).
This study advances the knowledge of necessary scientific evidence by assessing the specific impact of a multidimensional approach for VAP-which includes a bundle of infection-control interventions, education, outcome surveillance, process surveillance, and feedback of VAP rates and of infection-control practiceson the reduction of the frequency of VAP in 44 AICUs of 38 INICC member hospitals in 14 developing countries of four continents.
METHODS
Setting and Study Design. This beforeafter, prospective cohort study was carried out in 44 AICUs of 38 INICC member hospitals, in 14 developing countries, of four continents, namely: Argentina, Brazil, China, Colombia, Costa Rica, Cuba, India, Lebanon, Macedonia, Mexico, Morocco, Panama, Peru, and Turkey. These hospitals have actively participated in the INICC surveillance program for at least 1 yr, with an infection-control team comprising a medical doctor with formal education and background in infectious diseases, internal medicine, and/or hospital epidemiology, and infection-control professionals.
The study period was 12 yrs and 8 months, from March 1999 to January 2011, and was divided into two phases: phase 1 (baseline period, consisting in the first 3 months of participation in the INICC program), and phase 2 (intervention period). The Institutional Review Board at each hospital approved the study protocol.
Intervention Period. The intervention period started after 3 months of participation in the INICC surveillance program. The average length of the intervention period was 35.2 months ± sd 17.1 (range 12-57). The INICC multidimensional approach includes the following practices: 1) bundle of infection-control interventions; 2) education; 3) outcome surveillance; 4) process surveillance; 5) feedback of VAP rates; and 6) performance feedback of infection-control practices.
INICC Methodology. The INICC surveillance program includes two components: outcome surveillance (VAP rates and consequences) and process surveillance (adherence to hand hygiene (HH) and other basic preventive infection-control practices (7)).
The investigators at the participating hospitals were required to perform outcome and process surveillance by completing forms, which were then sent for their monthly analysis to the INICC office in Buenos Aires (7) .
Outcome Surveillance. The INICC Surveillance Program is focused on the methods and definitions for DAI developed by the U.S. Centers for Disease Control and Prevention for the National Nosocomial Infection Surveillance System/National Health Safety Network program (26, 27) . However, the INICC methods have taken into consideration the different socioeconomic status and specific limitations of limited-resource countries, and were adapted for their application in this setting (7) . Outcome su rveillance includes rates VAP per 1000 device days, microorganism profile, bacterial resistance, LOS, and mortality in their ICUs.
Process Surveillance. Preventive strategies in INICC member hospitals are based on simple, inexpensive, evidence-based measures, which include outcome surveillance, process surveillance, education, and performance feedback of outcome surveillance and process surveillance (7) .
Process surveillance is designed to monitor compliance with easily measurable, key infection-control measures. It includes the surveillance of compliance rates for hand-hygiene (HH) practices and some specific infectioncontrol measures for the prevention of VAP (23) (24) (25) 28) .
HH compliance by healthcare workers is determined by measuring the frequency of HH performances when clearly indicated, and such practices are monitored by the hospital's infection-control professionals during randomly selected 1-hr observation periods, three times a week. Although healthcare workers know that HH practices are regularly monitored, they are not actually aware of the precise moment in which observations are taking place (7) .
Infection-control professionals were trained to detect HH compliance and record HH opportunities and compliance through direct observation. The INICC direct observation comprises the "Five Moments for Hand Hygiene," as recommended by the World Health Organization. The Five Moments were designed on the basis of the evidence concerning DAI prevention and control, and include the monitoring of the following moments: 1) before patient contact; 2) before an aseptic task; 3) after body-fluid exposure risk; 4) after patient contact; and 5) after contact with patient surroundings (29) .
Training and Validation. The INICC Chairman trained the principal and secondary investigators at hospitals from Argentina, Colombia, India, Mexico, and Turkey. In the remaining countries, investigators were selftrained by means of a manual and training tool, which described how to perform surveillance and complete surveillance forms. Investigators have continuous e-mail and telephonic access to a support team at the INICC Central Office in Buenos Aires, Argentina, which is in charge of responding to all queries within 24 hrs. The INICC Chairman further reviews all queries and responses.
Surveillance forms for individual patients allow internal and external validation, because they include every clinical and microbiological criterion for each type of DAI, such as temperature, blood pressure, use if invasive devices, cultures taken, culture results, antibiotic use. Surveillance also includes a form in which positive cultures are registered and matched with patients' forms.
On a monthly basis, participating hospitals submitted the completed surveillance forms to the INICC Central Office, where the validity of each case was checked and the recorded signs and symptoms of infection and the results of laboratory studies, radiographic studies, and cultures were scrutinized to assure that the National Nosocomial Infection Surveillance System criteria for device-associated infection were fulfilled.
The infection control team member who reviewed the forms completed at the participating AICU was able to verify that criteria for infection had been met accurately in each patient. Additionally, the original patient data forms were further validated at the INICC Central Office, before data on the reported infection were entered into the INICC's database. To that end, queries were submitted from INICC office in Buenos Aires to the ICT teams at each hospital, challenging those cases with suspected VAP, and data were uploaded after receiving the reply from hospital teams. Finally, the INICC team performed consistency analyses of database, such as age, sex, dates, among other data, and reviews of medical records that compared data registered in forms and data in medical records.
Performance Feedback. The concept of using performance feedback of outcome surveillance and process surveillance as a valuable control measure in limited-resource hospitals was based on its effectiveness as proved in previous INICC studies (21) (22) (23) (24) (25) 28) .
The INICC Central Office team prepared and sent monthly chart reports to each participating hospital, which detailed their rates of VAP, microbiology profile, and rates of adherence to HH, among other infectionrelated data.
The participating ICU staff received feedback on their performance at monthly meetings, by means of the review of the monthly charts, which were posted in a prominent location in the ICU. We performed direct observation of HH compliance, duration of the ventilation, and ventilation ratio use, using a structured observation tool at regularly scheduled intervals (7) .
Definitions. We applied Centers for Disease Control and Prevention National Health Safety Network definitions for VAP (27) . VAP is diagnosed in a mechanically ventilated patient with a chest radiograph that shows new or progressive infiltrates, consolidation, cavitation, or pleural effusion. The patient also must meet at least one of the following criteria: new onset of purulent sputum or change in character of sputum, organism cultured from blood, or isolation of an etiologic agent from a specimen obtained by tracheal aspirate, bronchial brushing or bronchoalveolar lavage, or biopsy (27) .
Statistical Methods. Patients' characteristics during baseline and during intervention period in each AICU were compared using Fisher's exact test for dichotomous variables and unmatched Student's t test for continuous variables. Relative risk ratios with 95% confidence intervals were calculated for comparison of rates at baseline and subsequent intervention period.
To analyze the time evolution of VAP rates in AICUs, we performed a time-series analysis of VAP rate, as a variable, during the whole study period. We used a regression model with Tables 1 and 2) .
RESULTS

During the
Patients characteristics were similar during both periods, although average severity of illness score was lower and the percentage of patients with cardiac failure was higher (see Table 2 ).
Regarding process surveillance, we found that semirecumbent position was 85.1%, and was improved by 6%, removal of the mucus from ventilator circuits was 80.7%, and was improved by 5%, HH compliance compliance was improved by 17%, nebulizer without turbidity was improved by 27%, absence of pharyngeal lake was improved by 18%; however, removal of the condensate from ventilator circuits (73%), and respiratory therapy done (92.5%) did not improve significantly (see Table 3 ). During baseline, the VAP rate was 22.0 VAPs per 1000 MV days, and during intervention VAP rate was 17.2 per 1,000 MV days (relative risk 0.78; 95% confidence interval 0.68-0.90; p <.0004). These results showed a 22% VAP rate reduction (see Table 4 ).
A time-series analysis was carried out, and the estimated model from available data was the following: VAP_rate = 22.491-0.211 t; that is, the VAP rate at the start of the intervention period was 22. The R 2 obtained was .681, and LjungBox Q statistic indicated the absence of statistically significant autocorrelations in residuals (Q = 11.144, df = 18, significance = 0.888).
The adjusted model of linear trend shows a 55.83% reduction of the rate of VAP at the end of the study period; that is, the VAP rate is 55.83% lower than it was at the beginning of phase 2. (Fig. 1) Microorganisms profile is shown in Table 5 .
Antibiotic resistance and antibiotic use are shown in Tables 6 and 7 , respectively.
DISCUSSION
In many studies, it has been demonstrated that VAP is associated with increased hospital LOS (3, 41),excess healthcare costs (3), and increased attributable mortality (41) .The fact that patients hospitalized in ICUs frequently require mechanical ventilation makes them especially vulnerable to develop VAP. Unfortunately, many healthcare institutions in developing countries lack basic infection-control programs and most caregivers are unaware of VAP rates at their healthcare facilities (2, 5, 6, 9-18, 42, 43).
Reducing DAIs has been considered a primary healthcare matter that needs immediate attention (44) . As reported in different studies from the United States, the frequency of DAI can be reduced by as much as 30%, leading to a correlated decrease in hospital costs (45) . The implementation of a multidimensional approach for VAP reduction proved effective a long time ago. It has been demonstrated in different studies that VAP prevalence can be substantially prevented through effective basic interventions, such as HH (46), semirecumbent positioning (47) , early removal of endotracheal tubes (48) , maintenance of endotracheal cuff pressure, and continuous subglottic suctioning (49) .
In our study, we noticed a significant improvement in semirecumbent position, removal of the mucus from ventilator circuits, HH compliance, nebulizer without turbidity, and absence of pharyngeal lake; however, removal of the condensate from ventilator circuits, and respiratory therapy done did not improve significantly. Mechanical ventilator use ratio: mechanical ventilator use ratios were calculated by dividing the total number of mechanical ventilator days by the total number of patient days. Mechanical ventilator days are the total number of days of exposure to mechanical ventilation by all the patients in the selected population during the selected time period. Patient days are the total number of days that patients are in the intensive care unit during the selected time period. In general, patients' characteristics were similar during both periods, although ASIS score was lower and the percentage of patients with cardiac failure was higher during the intervention period.
On the one hand, we noticed a significant reduction in patients with usage of antibiotic, a reduction in patients using quinolones, and ceftriaxone; but on the other, we also noticed a reduction in LOS. Probably both reductions, in antibiotic usage and LOS, resulted from the reduction in VAP rates after adopting the multidimensional approach.
Infection-control professionals need to implement a VAP preventive strategy based on the accurate knowledge of VAP rates at their institutions, so as to approach the problem with cost-effective preventive measures. The positive impact of multidimensional infection-control programs that focus on educational interventions has been shown in many studies (6, 21, 23, (49) (50) (51) (52) (53) (54) .
However, such educational efforts may be short-lived if regular reinforcement is absent. Similarly, a reduction in VAP rates cannot be expected to derive from surveillance by itself, unless the collection of this data is used for the improvement of patient-care practices, such as performance feedback (21, 22). Therefore, it is essential to support educational efforts with regular feedback in the form of monthly occurrence rates of VAPs to derive substantial benefit from preventive strategies (21, 22, 28, 54, 55) .
VAP control may not be sufficient or feasible if a single measure is implemented, but it requires a culture change involving the entire ICU team (doctors, nurses, respiratory therapists (19) ). It was shown in studies performed by INICC that implementation of a multifaceted prevention model for VAP, which includes a bundle of interventions, such as outcome and process surveillance, education, feedback of VAP rates, and performance feedback, resulted in a significant reduction in rates of VAP over the study period (21, 22, 28, 54, 55) .
Using a time-series analysis with a linear trend model, the rate of VAP was reduced by 55.83% in the participating AICUs by the end of the study. This reduction occurred during phase 2, after adopting the VAP prevention model. VAP, ventilator-associated pneumonia. Mechanical ventilator use ratio: Mechanical ventilator use ratios were calculated by dividing the total number of mechanical ventilator days by the total number of patient days. Mechanival ventilator days: the total number of days of exposure to mechanical ventilation by all of the patients in the selected population during the selected time period. Patient days: the total number of days that patients are in the intensive care unit during the selected time period. Within the scope of developing countries, this study is among the first few studies that have reported a substantial reduction in VAP rates in the AICU setting, proving the success of this kind of infection-control approach (1) .
For the future, we plan to include the process surveillance and performance feedback of other variables that could not be measured during this multidimensional approach, such as: performance of daily assessments of readiness to wean and use of weaning protocols, performance of regular comprehensive oral care with an antiseptic solution, use of noninvasive ventilation whenever possible and minimization of the duration of ventilation, preferable use of orotracheal instead of nasotracheal intubation; maintenance of an endotracheal cuff pressure of at least 20-cm H 2 O, avoidance of gastric overdistention, and avoidance of histamine receptor 2 (H 2 )-blocking agents and proton pump inhibitors.
It is noteworthy that VAP is considered a good quality indicator, and trained infection-control professionals are under great pressure to achieve improved VAP rates. This may result in a risk that healthcare workers may involuntary construe the VAP definition so as to attenuate manifest rates of VAP rates (19) . Despite this difficulty, infection-control professionals at the INICC AICU setting were able to obtain successful prevention of VAP. Although we are conscious of the challenge involved in sustaining present VAP rates indefinitely, and in improving them continously, we aim at improving compliance of the model for VAP prevention by upholding the motivation of the AICU team.
CONCLUSIONS
We expect that these preventive strategies, which have proven to be effective in the INICC AICUs by means of the implementation of the multidimensional approach for VAP prevention, result in a wider acceptance of infection-control programs in hospitals worldwide, leading to significant VAP reductions, thus. For that reason, any hospital may participate in the INICC network, which was set up to respond to the compelling need in the developing world to significantly prevent, control, and reduce VAPs and their adverse effects. Through the INICC network, investigators are freely furnished with training and methodological tools to perform outcome and process surveillance, and to implement an effective infection-prevention model for VAPs, and at the same time, the publication of these findings serves to foster relevant scientific evidence-based literature. 9 
